Martin MM, Wu SM, Martin AL, Rennert OM, Chan WY

Testicular seminoma in a patient with a constitutively activating mutation of the luteinizing hormone/chorionic gonadotropin receptor.

Eur J Endocrinol 139:101-6 (1998)
DOI:10.1530/eje.0.1390101

Kosugi S, Van Dop C, Geffner ME, Rabl W, Carel JC, Chaussain JL, Mori T, Merendino JJ Jr, Shenker A

Characterization of heterogeneous mutations causing constitutive activation of the luteinizing hormone receptor in familial male precocious puberty.

Hum Mol Genet 4:183-8 (1995)
DOI:10.1093/hmg/4.2.183

Yano K, Saji M, Hidaka A, Moriya N, Okuno A, Kohn LD, Cutler GB Jr

A new constitutively activating point mutation in the luteinizing hormone/choriogonadotropin receptor gene in cases of male-limited precocious puberty.

J Clin Endocrinol Metab 80:1162-8 (1995)
DOI:10.1210/jcem.80.4.7714085

Qiao J, Han B

Diseases caused by mutations in luteinizing hormone/chorionic gonadotropin receptor.

Prog Mol Biol Transl Sci 161:69-89 (2019)
DOI:10.1016/bs.pmbts.2018.09.007

Narayan P

Genetic Models for the Study of Luteinizing Hormone Receptor Function.

Front Endocrinol (Lausanne) 6:152 (2015)
DOI:10.3389/fendo.2015.00152

Ulloa-Aguirre A, Reiter E, Bousfield G, Dias JA, Huhtaniemi I

Constitutive activity in gonadotropin receptors.

Adv Pharmacol 70:37-80 (2014)
DOI:10.1016/B978-0-12-417197-8.00002-X